119 related articles for article (PubMed ID: 12368372)
1. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
Antoch G; Freudenberg LS; Egelhof T; Stattaus J; Jentzen W; Debatin JF; Bockisch A
J Nucl Med; 2002 Oct; 43(10):1339-42. PubMed ID: 12368372
[TBL] [Abstract][Full Text] [Related]
2. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
3. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT.
Büther F; Stegger L; Dawood M; Range F; Schäfers M; Fischbach R; Wichter T; Schober O; Schäfers KP
J Nucl Med; 2007 Jul; 48(7):1060-8. PubMed ID: 17574981
[TBL] [Abstract][Full Text] [Related]
4. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer T; Antoch G; Bockisch A; Stattaus J
J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
[TBL] [Abstract][Full Text] [Related]
5. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials.
Antoch G; Freudenberg LS; Stattaus J; Jentzen W; Mueller SP; Debatin JF; Bockisch A
AJR Am J Roentgenol; 2002 Dec; 179(6):1555-60. PubMed ID: 12438054
[TBL] [Abstract][Full Text] [Related]
6. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.
Nakamoto Y; Osman M; Cohade C; Marshall LT; Links JM; Kohlmyer S; Wahl RL
J Nucl Med; 2002 Sep; 43(9):1137-43. PubMed ID: 12215550
[TBL] [Abstract][Full Text] [Related]
7. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
[TBL] [Abstract][Full Text] [Related]
8. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
[TBL] [Abstract][Full Text] [Related]
9. Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer?
Nahmias C; Lemmens C; Faul D; Carlson E; Long M; Blodgett T; Nuyts J; Townsend D
J Nucl Med; 2008 Jul; 49(7):1047-52. PubMed ID: 18552154
[TBL] [Abstract][Full Text] [Related]
10. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
[TBL] [Abstract][Full Text] [Related]
11. Application of oral contrast media in coregistered positron emission tomography-CT.
Dizendorf EV; Treyer V; Von Schulthess GK; Hany TF
AJR Am J Roentgenol; 2002 Aug; 179(2):477-81. PubMed ID: 12130457
[TBL] [Abstract][Full Text] [Related]
12. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
13. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
[TBL] [Abstract][Full Text] [Related]
14. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
15. Initial experience with oral contrast in PET/CT: phantom and clinical studies.
Cohade C; Osman M; Nakamoto Y; Marshall LT; Links JM; Fishman EK; Wahl RL
J Nucl Med; 2003 Mar; 44(3):412-6. PubMed ID: 12621008
[TBL] [Abstract][Full Text] [Related]
16. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
[TBL] [Abstract][Full Text] [Related]
17. Respiration-induced attenuation artifact at PET/CT: technical considerations.
Goerres GW; Burger C; Kamel E; Seifert B; Kaim AH; Buck A; Buehler TC; Von Schulthess GK
Radiology; 2003 Mar; 226(3):906-10. PubMed ID: 12616024
[TBL] [Abstract][Full Text] [Related]
18. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
19. Highly iodinated intravenous contrast material for PET/CT - a feasibility study.
Heusner TA; Kuehl H; Veit-Haibach P; Hahn S; Boy C; Forsting M; Bockisch A; Antoch G
Rofo; 2008 Aug; 180(8):740-5. PubMed ID: 18642214
[TBL] [Abstract][Full Text] [Related]
20. Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images.
Halpern BS; Dahlbom M; Waldherr C; Yap CS; Schiepers C; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2004 Feb; 45(2):290-3. PubMed ID: 14960650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
